SAN DIEGO — Sydnexis Inc., a clinical stage biopharmaceutical company focused on the treatment of progressive myopia in children and minimizing the...
March 1, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Myopia is the primary eye health threat of the 21st century. The...
February 16, 2021 By Dwight Akerman, OD, MBA, FAAO Researchers from the Erasmus Medical Center Department of Ophthalmology in Rotterdam sought to...
February 16, 2021 By Dwight Akerman, OD, MBA Eye care professionals are often hesitant to prescribe standard or myopia management soft contact...
February 1, 2021 By Dwight Akerman, OD, MBA, FAAO Home confinement during the COVID-19 pandemic was associated with a significant myopic shift...
February 1, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA During the fourth quarter of 2020, Jobson Optical Research polled nearly 300...